- Report
- December 2022
- 85 Pages
Europe
From €3660EUR$4,000USD£3,180GBP
- Report
- November 2022
- 115 Pages
Global
From €4118EUR$4,500USD£3,578GBP
- Report
- February 2024
- 115 Pages
Global
From €4347EUR$4,750USD£3,777GBP
- Report
- February 2024
- 120 Pages
Global
From €4347EUR$4,750USD£3,777GBP
- Report
- February 2024
- 120 Pages
Global
From €4347EUR$4,750USD£3,777GBP
- Report
- April 2023
- 110 Pages
Global
From €4347EUR$4,750USD£3,777GBP
- Report
- April 2023
- 134 Pages
Global
From €4347EUR$4,750USD£3,777GBP
- Report
- April 2023
- 114 Pages
Global
From €4347EUR$4,750USD£3,777GBP
- Report
- August 2022
- 112 Pages
Global
From €4347EUR$4,750USD£3,777GBP
- Report
- January 2022
- 115 Pages
Global
From €4347EUR$4,750USD£3,777GBP
- Report
- January 2022
- 90 Pages
Europe
From €4347EUR$4,750USD£3,777GBP
- Report
- September 2023
- 50 Pages
Global
From €2288EUR$2,500USD£1,988GBP
- Report
- September 2023
- 182 Pages
Global
From €3660EUR$4,000USD£3,180GBP
- Report
- January 2024
- 150 Pages
Global
From €4438EUR$4,850USD£3,856GBP
- Report
- May 2023
- 150 Pages
Global
From €4438EUR$4,850USD£3,856GBP
- Report
- November 2023
- 76 Pages
Global
From €4118EUR$4,500USD£3,578GBP
- Report
- March 2024
Global
From €4438EUR$4,850USD£3,856GBP
- Report
- January 2022
- 194 Pages
Global
From €4072EUR$4,450USD£3,538GBP
- Report
- March 2024
- 200 Pages
Global
From €3798EUR$4,150USD£3,300GBP
- Report
- March 2024
- 200 Pages
Global
From €3798EUR$4,150USD£3,300GBP

The Biomarkers market is a sector of the healthcare industry that focuses on the development and use of biomarkers for the diagnosis, prognosis, and treatment of diseases. Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, or to monitor the progression of a disease. They can also be used to predict the response to a particular treatment. Biomarkers are typically proteins, nucleic acids, or metabolites that are found in the body and can be measured in a variety of ways.
Biomarkers are used in a variety of medical applications, including cancer diagnosis and treatment, cardiovascular disease, and neurological disorders. They are also used in drug development, to identify potential drug targets and to monitor the safety and efficacy of drugs.
Some of the major companies in the Biomarkers market include Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. Show Less Read more